Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 7 | BMC Cancer

Figure 7

From: The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis

Figure 7

Human prostate tissue samples stained with CD164. High-density tissue micro arrays of human CaP tumors were immunostained for CD164, AR and PSA as described in the methods. Immunostaining intensity was scored by a genito-urinary pathologist: as absent (1), weak (2), moderate (3) or strong (4). Scoring was performed blindly using a telepathology system without knowledge of overall the tumor grade, tumor size or clinical outcome [30]. Representative staining of CD164 staining for (A) benign prostate hyperplasia (B) localized prostate cancer (C) metastatic prostate cancer to bone marrow. Correlation of CD164 staining with prostate specific antigen (PSA) staining intensity (D), androgen receptor (E) and tissue type (F). The data demonstrate that CD164 staining intensity increases with increasing tumor grade.

Back to article page